Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates

被引:46
|
作者
Einarsson, Emil [2 ]
Sigurdsson, Jon Fridrik [3 ]
Gudjonsson, Gisli H. [1 ]
Newton, Anna Kristin [4 ]
Bragason, Olafur Orn [5 ]
机构
[1] Inst Psychiat, Dept Psychol, London SE5 8AF, England
[2] Univ Aarhus, Dept Psychol, Aarhus, Denmark
[3] Univ Iceland, Landspitali Univ Hosp, Div Psychiat, Reykjavik, Iceland
[4] Prison & Probat Adm, Reykjavik, Iceland
[5] Off Natl Commissioner Iceland Police, Reykjavik, Iceland
关键词
ADHD; Antisocial personality disorder; Prisoners; Psychiatric disorder; Substance misuse; NEUROPSYCHIATRIC INTERVIEW MINI; UTAH RATING-SCALE; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC STATUS; ADHD; BOYS; ASSOCIATION; VALIDATION; PREDICTORS; VALIDITY;
D O I
10.1080/08039480902759184
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder, which is associated with a number of psychiatric conditions, mostly personality disorder, substance misuse, anxiety and depression. The aim of the present study was to investigate the relationship between ADHD symptoms and associated psychiatric conditions among prisoners. The participants were 90 male prisoners in Iceland who were assessed within 10 days of admission to the prison. The Mini International Neuropsychiatric Interview (MINI) and the Standardised Assessment of Personality-Abbreviated Scale (SAPAS) were administered. Childhood ADHD symptoms were screened by the Wender-Utah Rating Scale and current adult symptoms by the DSM-IV Checklist for ADHD. Half of the prisoners (50%) were found on screening to have met criteria for ADHD in childhood and of those over half (60%) were either fully symptomatic or in partial remission of their symptoms. A logistic regression analysis revealed that the MINI Antisocial Personality Disorder scale was the single best predictor of current ADHD symptoms. Many prisoners are either fully symptomatic or in partial remission of their ADHD symptoms and have serious co-morbid problems, primarily associated with antisocial personality disorder and substance dependence. Prisoners should routinely undergo screening for ADHD in order to identify those who would benefit from a comprehensive assessment to determine who may have ADHD and associated problems.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [1] Prevalence of attention-deficit/hyperactivity disorder and co-morbid disorders among students of Cumhuriyet University
    Kavakci, Onder
    Kugu, Nesim
    Semiz, Murat
    Meydan, Feride
    Karsikaya, Sureyya
    Dogan, Orhan
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2012, 26 (02): : 107 - 117
  • [2] Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample
    Steinhausen, Hans-Christoph
    Bisgaard, Charlotte
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (02) : 232 - 241
  • [3] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Dell'Agnello, Grazia
    Zuddas, Alessandro
    Masi, Gabriele
    Curatolo, Paolo
    Besana, Dante
    Rossi, Andrea
    [J]. CNS DRUGS, 2009, 23 (09) : 739 - 753
  • [4] Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
    Grazia Dell’Agnello
    Alessandro Zuddas
    Gabriele Masi
    Paolo Curatolo
    Dante Besana
    Andrea Rossi
    [J]. CNS Drugs, 2009, 23 : 739 - 753
  • [5] Attention deficit hyperactivity disorder among inmates in Bergen Prison
    Stokkeland, Lisa
    Fasmer, Ole Bernt
    Waage, Leif
    Hansen, Anita L.
    [J]. SCANDINAVIAN JOURNAL OF PSYCHOLOGY, 2014, 55 (04) : 343 - 349
  • [6] Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction
    Perez de los Cobos, Jose
    Sinol, Nuria
    Perez, Victor
    Trujols, Joan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (02) : 337 - 356
  • [7] Discipline styles and co-morbid disorders of adolescents with attention deficit hyperactivity disorder: a longitudinal study
    Colomer-Diago, Carla
    Berenguer-Forner, Carmen
    Tarraga-Minguez, Raul
    Miranda-Casas, Ana
    [J]. REVISTA DE NEUROLOGIA, 2014, 58 : S31 - S36
  • [8] Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder
    Michael O Ogundele
    Hani F Ayyash
    [J]. World Journal of Clinical Pediatrics, 2018, (01) : 36 - 42
  • [9] Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
    Cunill, R.
    Castells, X.
    Tobias, A.
    Capella, D.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (01) : 15 - 23
  • [10] The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder
    Guenther, Thomas
    Herpertz-Dahlmann, Beate
    Jolles, Jellemer
    Konrad, Kerstin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 725 - 735